Vanguard Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-289,094
| Closed | -$37.6K | – | 4628 |
|
|
2023
Q1 | $37.6K | Sell |
289,094
-49,428
| -15% | -$10.1K | ﹤0.01% | 4495 |
|
|
2022
Q4 | $55.6K | Sell |
338,522
-777,284
| -70% | -$325K | ﹤0.01% | 4437 |
|
|
2022
Q3 | $726K | Buy |
1,115,806
+14,954
| +1% | +$22K | ﹤0.01% | 4096 |
|
|
2022
Q2 | $2.68M | Hold |
1,100,852
| – | – | ﹤0.01% | 3680 |
|
|
2022
Q1 | $4.45M | Sell |
1,100,852
-42,493
| -4% | -$233K | ﹤0.01% | 3590 |
|
|
2021
Q4 | $9.16M | Sell |
1,143,345
-1,477
| -0.1% | -$17.3K | ﹤0.01% | 3269 |
|
|
2021
Q3 | $22.1M | Buy |
1,144,822
+197,521
| +21% | +$3.45M | ﹤0.01% | 2814 |
|
|
2021
Q2 | $13.1M | Buy |
947,301
+38,665
| +4% | +$458K | ﹤0.01% | 3069 |
|
|
2021
Q1 | $8.2M | Buy |
908,636
+614,041
| +208% | +$4.49M | ﹤0.01% | 3262 |
|
|
2020
Q4 | $1.63M | Hold |
294,595
| – | – | ﹤0.01% | 3712 |
|
|
2020
Q3 | $952K | Hold |
294,595
| – | – | ﹤0.01% | 3668 |
|
|
2020
Q2 | $954K | Hold |
294,595
| – | – | ﹤0.01% | 3625 |
|
|
2020
Q1 | $663K | Hold |
294,595
| – | – | ﹤0.01% | 3608 |
|
|
2019
Q4 | $1.29M | Hold |
294,595
| – | – | ﹤0.01% | 3571 |
|
|
2019
Q3 | $1.5M | Buy |
294,595
+148,946
| +102% | +$867K | ﹤0.01% | 3536 |
|
|
2019
Q2 | $1.05M | Buy |
145,649
+32,874
| +29% | +$178K | ﹤0.01% | 3662 |
|
|
2019
Q1 | $592K | Buy |
112,775
+17,300
| +18% | +$84.6K | ﹤0.01% | 3743 |
|
|
2018
Q4 | $146K | Sell |
95,475
-67,956
| -42% | -$242K | ﹤0.01% | 3943 |
|
|
2018
Q3 | $662K | Buy |
163,431
+80,910
| +98% | +$304K | ﹤0.01% | 3805 |
|
|
2018
Q2 | $326K | Buy |
82,521
+62
| +0.1% | +$253 | ﹤0.01% | 3904 |
|
|
2018
Q1 | $276K | Buy |
82,459
+25,931
| +46% | +$164K | ﹤0.01% | 3910 |
|
|
2017
Q4 | $390K | Buy |
56,528
+21,027
| +59% | +$146K | ﹤0.01% | 3801 |
|
|
2017
Q3 | $231K | Buy |
+35,501
| New | +$228K | ﹤0.01% | 3888 |
|
|
2017
Q2 | – | Sell |
-14,371
| Closed | -$150K | – | 4087 |
|
|
2017
Q1 | $150K | Hold |
14,371
| – | – | ﹤0.01% | 3947 |
|
|
2016
Q4 | $184K | Sell |
14,371
-7,314
| -34% | -$269K | ﹤0.01% | 3903 |
|
|
2016
Q3 | $2.52M | Buy |
21,685
+1,898
| +10% | +$185K | ﹤0.01% | 3304 |
|
|
2016
Q2 | $1.57M | Buy |
19,787
+1,584
| +9% | +$137K | ﹤0.01% | 3462 |
|
|
2016
Q1 | $1.38M | Buy |
18,203
+978
| +6% | +$62.2K | ﹤0.01% | 3497 |
|
|
2015
Q4 | $1.54M | Buy |
17,225
+4,753
| +38% | +$456K | ﹤0.01% | 3493 |
|
|
2015
Q3 | $1.4M | Buy |
12,472
+824
| +7% | +$94.8K | ﹤0.01% | 3527 |
|
|
2015
Q2 | $1.18M | Buy |
11,648
+5,140
| +79% | +$532K | ﹤0.01% | 3615 |
|
|
2015
Q1 | $710K | Buy |
6,508
+1,909
| +42% | +$195K | ﹤0.01% | 3724 |
|
|
2014
Q4 | $419K | Buy |
4,599
+1,026
| +29% | +$87.5K | ﹤0.01% | 3782 |
|
|
2014
Q3 | $284K | Buy |
+3,573
| New | +$273K | ﹤0.01% | 3836 |
|
Other funds holding PLXP
Vanguard Group's PLXP Position: Q2 2023 in Review
Vanguard Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 289,094 shares — an estimated $37.6K sold.
Vanguard Group first reported a position in PLXP in Q3 2014 and held it in 34 quarters. The position peaked at $22.1M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.
- Vanguard Group reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Vanguard Group sold 289,094 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $37.6K.
- Vanguard Group first reported a position in PLx Pharma Inc. Common Stock in Q3 2014 and held it in 34 quarters.
- Vanguard Group's PLx Pharma Inc. Common Stock position peaked at $22.1M in Q3 2021.
- 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.
Based on Vanguard Group's 13F filing for Q2 2023, filed 14 Aug 2023.